Published in
Elsevier, Gynecologic Oncology, 2(157), p. 558-559, 2020
DOI: 10.1016/j.ygyno.2020.02.023
Elsevier, Gynecologic Oncology, 1(161), p. 328-329, 2021
DOI: 10.1016/j.ygyno.2021.01.032
Links
Tools
Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448]
Journal article published in 2020 by
Paul A. Cohen,
Aime Powell,
Steffen Bohm,
Steffen Böhm,
C. Blake Gilks,
Colin J. R. Stewart,
Tarek M. Meniawy,
Max Bulsara,
Stefanie Avril,
Eleanor C. Brockbank,
Tjalling Bosse,
Gustavo Rubino de Azevedo Focchi,
Raji Ganesan,
Rosalind M. Glasspool,
Brooke E. Howitt 
and other authors.
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 